Works by Hu, Yongxian

Results: 82

Cunninghamella bertholletiae Infection in a HLA-Haploidentical Hematopoietic Stem Cell Transplant Recipient with Graft Failure: Case Report and Review of the Literature.

Published in:

Mycopathologia, 2016, v. 181, n. 9/10, p. 753, doi. 10.1007/s11046-016-0030-7

By:

Luo, Chao;
Wang, Jiasheng;
Hu, Yongxian;
Luo, Yi;
Tan, Yamin;
Jin, Aiyun;
Wei, Bin;
Hu, Huixian;
Huang, He

Publication type:

Article

CAR-T cells for cancer immunotherapy—the barriers ahead and the paths through.

Published in:

International Reviews of Immunology, 2022, v. 41, n. 6, p. 567, doi. 10.1080/08830185.2022.2080820

By:

Zhang, Qiqi;
Zu, Cheng;
Hu, Yongxian;
Huang, He

Publication type:

Article

Long-term outcomes of antithymocyte globulin in patients with hematological malignancies undergoing myeloablative allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.

Published in:

Clinical Transplantation, 2013, v. 27, n. 2, p. E91, doi. 10.1111/ctr.12091

By:

Du, Kaili;
Hu, Yongxian;
Wu, Kangni;
Huang, He

Publication type:

Article

Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma.

Published in:

Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1125357

By:

Qiqi Zhang;
Cheng Zu;
Ruirui Jing;
Youqin Feng;
Yanlei Zhang;
Mingming Zhang;
Yuqi Lv;
Jiazhen Cui;
Linhui Zhou;
Ye Meng;
Linqin Wang;
Zenan Cen;
Chang, Alex H.;
Yongxian Hu;
He Huang

Publication type:

Article

Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell Lymphoma Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy.

Published in:

Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1462, doi. 10.4143/crt.2017.473

By:

Yongxian Hu;
Jiasheng Wang;
Chengfei Pu;
Kui Zhao;
Qu Cui;
Guoqing Wei;
Wenjun Wu;
Lei Xiao;
Yang Xiao;
Jinping Wang;
Zhao Wu;
He Huang

Publication type:

Article

Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy.

Published in:

Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0299-5

By:

Yongxian Hu;
Jie Sun;
Zhao Wu;
Jian Yu;
Qu Cui;
Chengfei Pu;
Bin Liang;
Yi Luo;
Jimin Shi;
Aiyun Jin;
Lei Xiao;
He Huang

Publication type:

Article

Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.

Published in:

Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-014-0099-8

By:

Kaimin Hu;
Yanjun Gu;
Lixia Lou;
Lizhen Liu;
Yongxian Hu;
Binsheng Wang;
Yi Luo;
Jimin Shi;
Xiaohong Yu;
He Huang

Publication type:

Article

Galectin-3 mediates bone marrow microenvironment-induced drug resistance in acute leukemia cells via Wnt/β-catenin signaling pathway.

Published in:

Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-014-0099-8

By:

Kaimin Hu;
Yanjun Gu;
Lixia Lou;
Lizhen Liu;
Yongxian Hu;
Binsheng Wang;
Yi Luo;
Jimin Shi;
Xiaohong Yu;
He Huang

Publication type:

Article

Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China.

Published in:

Journal of Medical Economics, 2023, v. 26, n. 1, p. 701, doi. 10.1080/13696998.2023.2207742

By:

Wu, Weijia;
Ding, Shuyi;
Mingming, Zhang;
Yuping, Zhou;
Sun, Xueshan;
Zhao, Zixuan;
Yang, Yi;
Hu, Yongxian;
Dong, Hengjin

Publication type:

Article

Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.

Published in:

2017

By:

Zheng, Yulong;
Jiang, Lihua;
Hu, Yongxian;
Xiao, Cheng;
Xu, Nong;
Zhou, Jianying;
Zhou, Xinhui

Publication type:

journal article

The CD226‐ERK1/2‐LAMP1 pathway is an important mechanism for Vγ9Vδ2 T cell cytotoxicity against chemotherapy‐resistant acute myeloid leukemia blasts and leukemia stem cells.

Published in:

Cancer Science, 2021, v. 112, n. 8, p. 3233, doi. 10.1111/cas.15014

By:

Wu, Kangni;
Wang, Li‐mengmeng;
Liu, Meng;
Xiu, Yanghui;
Hu, Yongxian;
Fu, Shan;
Huang, He;
Xu, Bing;
Xiao, Haowen

Publication type:

Article

Nutritional status alterations after chimeric antigen receptor T cell therapy in patients with hematological malignancies: a retrospective study.

Published in:

Supportive Care in Cancer, 2022, v. 30, n. 4, p. 3321, doi. 10.1007/s00520-021-06639-2

By:

Ding, Shuyi;
Cai, Lingxia;
Jin, Aiyun;
Zhou, Xiaoyu;
Yan, Jiali;
Wang, Linqin;
Zhao, Houli;
Wang, Tingting;
Hu, Yongxian

Publication type:

Article

Improved survival for young acute leukemia patients following a new donor hierarchy for allogeneic hematopoietic stem cell transplantation: A phase III randomized controlled study.

Published in:

American Journal of Hematology, 2021, v. 96, n. 11, p. 1429, doi. 10.1002/ajh.26317

By:

Zhang, Mingming;
Xiao, Haowen;
Shi, Jimin;
Tan, Yamin;
Zhao, Yanmin;
Yu, Jian;
Lai, Xiaoyu;
Hu, Yongxian;
Zheng, Weiyan;
Luo, Yi;
Huang, He

Publication type:

Article

γδ T cell and other immune cells crosstalk in cellular immunity.

Published in:

2014

By:

He, Ying;
Wu, Kangni;
Hu, Yongxian;
Sheng, Lixia;
Tie, Ruxiu;
Wang, Binsheng;
Huang, He

Publication type:

journal article

γδ T Cell and Other Immune Cells Crosstalk in Cellular Immunity.

Published in:

Journal of Immunology Research, 2014, p. 1, doi. 10.1155/2014/960252

By:

Ying He;
Kangni Wu;
Yongxian Hu;
Lixia Sheng;
Ruxiu Tie;
Binsheng Wang;
He Huang

Publication type:

Article

The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies.

Published in:

Biomarker Research, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40364-022-00375-3

By:

Zhou, Qinfeng;
Xie, Dacheng;
Wang, Rong;
Liu, Lianfang;
Yu, Yue;
Tang, Xinyi;
Hu, Yongxian;
Cui, Dawei

Publication type:

Article

Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.

Published in:

2022

By:

Wang, Huafeng;
Yang, Chang;
Shi, Ting;
Zhang, Yi;
Qian, Jiejing;
Wang, Yungui;
Hu, Yongxian;
Mao, Liping;
Ye, Xiujin;
Liu, Fang;
Xi, Zhenfang;
Shou, Lihong;
Fu, Caiyun;
Naranmandura, Hua;
Jin, Jie;
Zhu, Hong-Hu

Publication type:

Letter

A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia.

Published in:

2020

By:

Wang, Yiyun;
Yang, Yingying;
Hong, Ruimin;
Zhao, Houli;
Wei, Guoqing;
Wu, Wenjun;
Xu, Huijun;
Cui, Jiazhen;
Zhang, Yanlei;
Chang, Alex H.;
Hu, Yongxian;
Huang, He

Publication type:

Letter

Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.755584

By:

Wang, Yiyun;
Wang, Linqin;
Zeng, Yifan;
Hong, Ruimin;
Zu, Cheng;
Yin, Elaine Tan Su;
Zhao, Houli;
Wei, Guoqing;
Yang, Li;
Jin, Aiyun;
Hu, Yongxian;
Huang, He

Publication type:

Article

Efficacy and Safety of Chimeric Antigen Receptor T Cells in Acute Lymphoblastic Leukemia With Post-Transplant Relapse.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.750218

By:

Ding, Lijuan;
Wang, Yiyun;
Hong, Ruimin;
Zhao, Houli;
Zhou, Linghui;
Wei, Guoqing;
Wu, Wenjun;
Xu, Huijun;
Zhang, Yanlei;
Luo, Yi;
Shi, Jimin;
Chang, Alex H.;
Hu, Yongxian;
Huang, He

Publication type:

Article

Tumor Burden Measured by 18F-FDG PET/CT in Predicting Efficacy and Adverse Effects of Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.713577

By:

Hong, Ruimin;
Tan Su Yin, Elaine;
Wang, Linqin;
Zhao, Xin;
Zhou, Linghui;
Wang, Guangfa;
Zhang, Mingming;
Zhao, Houli;
Wei, Guoqing;
Wang, Yiyun;
Wu, Wenjun;
Zhang, Yafei;
Ni, Fang;
Hu, Yongxian;
Huang, He;
Zhao, Kui

Publication type:

Article

New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.702644

By:

Wang, Linqin;
Hong, Ruimin;
Zhou, Linghui;
Ni, Fang;
Zhang, Mingming;
Zhao, Houli;
Wu, Wenjun;
Wang, Yiyun;
Ding, Shuyi;
Chang, Alex H.;
Hu, Yongxian;
Huang, He

Publication type:

Article

Immunotherapy of lymphomas with T cells modified by anti-CD20 scFv/CD28/CD3ζ recombinant gene.

Published in:

Leukemia & Lymphoma, 2008, v. 49, n. 7, p. 1368, doi. 10.1080/10428190802064958

By:

Yu, Kang;
Hu, Yongxian;
Tan, Yinxia;
Shen, Zhijian;
Jiang, Songfu;
Qian, Honglan;
Liang, Bin;
Shan, Daming

Publication type:

Article

Using Tocilizumab in Hematologic Malignant Patients with Severe COVID-19 Infection – Case Series Report.

Published in:

2024

By:

Fu, Chunlan;
Zhu, Yuanyuan;
Huang, Weijia;
Luo, Yi;
Hu, Yongxian;
Huang, He;
Sun, Jie

Publication type:

Case Study

Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory Multiple Myeloma.

Published in:

Current Oncology, 2022, v. 29, n. 2, p. 490, doi. 10.3390/curroncol29020044

By:

Zu, Cheng;
Xu, Yufeng;
Wang, Yiyun;
Zhang, Mingming;
Zhao, Houli;
Fang, Xiaoyun;
Huang, He;
Hu, Yongxian

Publication type:

Article

How can we improve the successful identification of patients suitable for CAR-T cell therapy?

Published in:

Expert Review of Molecular Diagnostics, 2024, v. 24, n. 9, p. 777, doi. 10.1080/14737159.2024.2399152

By:

Feng, Youqin;
Wu, Longyuan;
Gu, Tianning;
Hu, Yongxian;
Huang, He

Publication type:

Article

The effectiveness of interferon-α combined with imatinib in patient with chronic myeloid leukemia harboring T315I BCR-ABL1 mutation.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 12, p. 3018, doi. 10.1080/10428194.2018.1443329

By:

Zhang, Hao;
Liang, Zuyu;
Hu, Yongxian;
Wang, Xiujian;
Wang, Binsheng;
Huang, He

Publication type:

Article

SNX2–ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.

Published in:

2017

By:

Mu, Qitian;
Guo, Lieping;
Hu, Yongxian;
Sheng, Lixia;
Zhang, Yi;
Wu, Ningning;
Chen, Ying;
Shi, Cong;
Shi, Songqiu;
Wu, Ying;
Ouyang, Guifang

Publication type:

Letter to the Editor

Impact of tocilizumab on anti‐CD19 chimeric antigen receptor T‐cell therapy in B‐cell acute lymphoblastic leukemia.

Published in:

Cancer (0008543X), 2024, v. 130, n. 15, p. 2660, doi. 10.1002/cncr.35316

By:

Wang, Xiangmin;
Zhang, Bingpei;
Zhang, Qing;
Zhou, Hongyuan;
Sun, Qian;
Zhou, Yi;
Li, Tianci;
Zhou, Dian;
Shen, Ziyuan;
Zhang, Jiaoli;
Li, Ping;
Liang, Aibin;
Zhou, Keshu;
Han, Lu;
Hu, Yongxian;
Yang, Yun;
Cao, Jiang;
Li, Zhenyu;
Xu, Kailin;
Sang, Wei

Publication type:

Article

Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations.

Published in:

2024

By:

Yang, Tingting;
Chen, Rongrong;
Zhang, Mingming;
Jing, Ruirui;
Geng, Jia;
Wei, Guoqing;
Luo, Yi;
Xiao, Pingnan;
Hong, Ruimin;
Feng, Jingjing;
Fu, Shan;
Zhao, Houli;
Cui, Jiazhen;
Huang, Simao;
Huang, He;
Hu, Yongxian

Publication type:

Case Study

HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic γδ T-cell Lymphoma.

Published in:

Cell Transplantation, 2023, v. 32, p. 1, doi. 10.1177/09636897231194265

By:

Xu, Xueer;
Zu, Cheng;
Zhang, Mingming;
Xiao, Pingnan;
Hong, Ruimin;
Feng, Jingjing;
Xu, Huijun;
Cui, Jiazhen;
Yu, Jian;
Shi, Jimin;
Wei, Guoqing;
Chang, Alex H.;
Huang, He;
Hu, Yongxian

Publication type:

Article

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies.

Published in:

Cell Transplantation, 2021, v. 30, p. 1, doi. 10.1177/09636897211025503

By:

Zhu, Feng;
Wei, Guoqing;
Liu, Yandan;
Zhou, Houli;
Wu, Wenjun;
Yang, Luxin;
Huang, He;
Hu, Yongxian

Publication type:

Article

Factors Associated with Costs in Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed/Refractory B-Cell Malignancies.

Published in:

Cell Transplantation, 2020, v. 29, p. 1, doi. 10.1177/0963689720919434

By:

Zhu, Feng;
Wei, Guoqing;
Zhang, Mingming;
Zhao, Houli;
Wu, Wenjun;
Yang, Luxin;
Hu, Yongxian;
Huang, He

Publication type:

Article

CAR-T Cell Therapy: Advances in Kidney-Related Diseases.

Published in:

Kidney Diseases, 2024, v. 10, n. 2, p. 143, doi. 10.1159/000536194

By:

Wu, Longyuan;
Feng, Youqin;
Huang, Yue;
Feng, Jingjing;
Hu, Yongxian;
Huang, He

Publication type:

Article

Integrated Single-Cell Bioinformatics Analysis Reveals Intrinsic and Extrinsic Biological Characteristics of Hematopoietic Stem Cell Aging.

Published in:

Frontiers in Genetics, 2021, v. 12, p. 1, doi. 10.3389/fgene.2021.745786

By:

Zeng, Xiangjun;
Li, Xia;
Shao, Mi;
Xu, Yulin;
Shan, Wei;
Wei, Cong;
Li, Xiaoqing;
Wang, Limengmeng;
Hu, Yongxian;
Zhao, Yanmin;
Qian, Pengxu;
Huang, He

Publication type:

Article

Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study.

Published in:

OncoImmunology, 2017, v. 6, n. 3, p. N.PAG, doi. 10.1080/2162402X.2016.1277307

By:

Tan, Yamin;
Xiao, Haowen;
Wu, Depei;
Luo, Yi;
Lan, Jianping;
Liu, Qifa;
Yu, Kang;
Shi, Jimin;
He, Jingsong;
Zheng, Weiyan;
Lai, Xiaoyu;
Zhu, Yuanyuan;
Du, Kaili;
Ye, Yishan;
Zhao, Yanmin;
Zheng, Gaofeng;
Hu, Yongxian;
Han, Xiaoyan;
Zheng, Yanlong;
Wei, Guoqing

Publication type:

Article

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies.

Published in:

Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32960-3

By:

Hu, Yongxian;
Li, Jingjing;
Ni, Fang;
Yang, Zhongli;
Gui, Xiaohua;
Bao, Zhiwei;
Zhao, Houli;
Wei, Guoqing;
Wang, Yiyun;
Zhang, Mingming;
Hong, Ruimin;
Wang, Linqin;
Wu, Wenjun;
Mohty, Mohamad;
Nagler, Arnon;
Chang, Alex H.;
van den Brink, Marcel R. M.;
Li, Ming D.;
Huang, He

Publication type:

Article

Acute lymphoblastic leukemia relapse after CD19‐targeted chimeric antigen receptor T cell therapy.

Published in:

Journal of Leukocyte Biology, 2017, v. 102, n. 6, p. 1347, doi. 10.1189/jlb.5RU0817-315R

By:

Wang, Jiasheng;
Hu, Yongxian;
Huang, He

Publication type:

Article

Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.

Published in:

2017

By:

Ye, Yishan;
Zheng, Weiyan;
Wang, Jiasheng;
Hu, Yongxian;
Luo, Yi;
Tan, Yamin;
Shi, Jimin;
Zhang, Mingming;
Huang, He

Publication type:

journal article

Reduction of Foxp3+ T cell subsets involved in incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Published in:

2017

By:

Hu, Yongxian;
Cui, Qu;
Ye, Yishan;
Luo, Yi;
Tan, Yamin;
Shi, Jimin;
Huang, He

Publication type:

journal article

PICALM-MLLT10 fusion gene in hematological neoplasms: clinical features, current practices, and prognoses.

Published in:

Hematology, 2024, v. 29, n. 1, p. 1, doi. 10.1080/16078454.2024.2423324

By:

Wang, Ji-nuo;
Ye, Bangcheng;
Cheng, Fei;
Yang, Li;
Hu, Yongxian;
Zheng, Gaofeng;
Cai, Zhen;
Yu, Jian;
Wu, Wenjun

Publication type:

Article

Cytokine Release Syndrome Is an Independent Risk Factor Associated With Platelet Transfusion Refractoriness After CAR-T Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia.

Published in:

Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.702152

By:

Liu, Yadan;
Liang, Bin;
Liu, Yan;
Wei, Guoqing;
Wu, Wenjun;
Yang, Luxin;
Yang, Li;
Huang, He;
Xie, Jue;
Hu, Yongxian

Publication type:

Article

A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma.

Published in:

Frontiers of Medicine, 2020, v. 14, n. 6, p. 711, doi. 10.1007/s11684-020-0808-3

By:

Zhao, Houli;
Wang, Yiyun;
Yin, Elaine Tan Su;
Zhao, Kui;
Hu, Yongxian;
Huang, He

Publication type:

Article

Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies.

Published in:

2024

By:

Hu, Yongxian;
Li, Jingjing;
Ni, Fang;
Yang, Zhongli;
Gui, Xiaohua;
Bao, Zhiwei;
Zhao, Houli;
Wei, Guoqing;
Wang, Yiyun;
Zhang, Mingming;
Hong, Ruimin;
Wang, Linqin;
Wu, Wenjun;
Mohty, Mohamad;
Nagler, Arnon;
Chang, Alex H.;
van den Brink, Marcel R. M.;
Li, Ming D.;
Huang, He

Publication type:

Correction Notice

Integrating genomic features for prognosis in Chinese patients with B-cell lymphoma following chimeric antigen receptor T-cell therapy.

Published in:

SCIENCE CHINA Life Sciences, 2025, v. 68, n. 6, p. 1703, doi. 10.1007/s11427-024-2783-2

By:

Zhou, Linghui;
Feng, Youqin;
Hong, Ruimin;
Wei, Guoqing;
Zhang, Mingming;
Chang, Alex H.;
Huang, He;
Hu, Yongxian

Publication type:

Article

CAR-T cells: the Chinese experience.

Published in:

Expert Opinion on Biological Therapy, 2020, v. 20, n. 11, p. 1293, doi. 10.1080/14712598.2020.1790521

By:

Wang, Linqin;
Tan Su Yin, Elaine;
Zhao, Houli;
Ni, Fang;
Hu, Yongxian;
Huang, He

Publication type:

Article

CD19 targeted CAR-T therapy versus chemotherapy in re-induction treatment of refractory/relapsed acute lymphoblastic leukemia: results of a case-controlled study.

Published in:

2018

By:

Wei, Guoqing;
Hu, Yongxian;
Yu, Jian;
Luo, Yi;
Shi, Jimin;
Wu, Wenjun;
Huang, He;
Pu, Chengfei;
Wang, Jinping;
Xiao, Lei;
Wu, Zhao;
Cui, Qu

Publication type:

journal article

Bone marrow mesenchymal stromal cells affect the cell cycle arrest effect of genotoxic agents on acute lymphocytic leukemia cells via p21 down-regulation.

Published in:

Annals of Hematology, 2014, v. 93, n. 9, p. 1499, doi. 10.1007/s00277-014-2069-1

By:

Zhang, Yiran;
Hu, Kaimin;
Hu, Yongxian;
Liu, Lizhen;
Wang, Binsheng;
Huang, He

Publication type:

Article

The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS).

Published in:

BMC Medical Imaging, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12880-021-00674-5

By:

Zhang, Yafei;
Wang, Guangfa;
Zhao, Xin;
Hu, Yongxian;
Tan Su Yin, Elaine;
Chen, Donghe;
Wang, Huatao;
Zhao, Kui

Publication type:

Article

Correction to: Decitabine plus CLAG chemotherapy as a bridge to haploidentical transplantation in the setting of acute myeloid leukemia relapse after HLA-matched sibling transplantation: a case report.

Published in:

2019

By:

Jin, Mengqi;
Hu, Yongxian;
Wu, Wenjun;
Luo, Yi;
Tan, Yamin;
Yu, Jian;
Jin, Aiyun;
Yang, Luxin;
Huang, He;
Wei, Guoqing

Publication type:

journal article